archive for rxn to recent headlines
Hospital players and deals you should know about in Asia : Country briefs: China, India, and Indonesia
Hospital markets country briefs China We have explored the many trends driving the growth in China’s healthcare market in the above sections. With the recent policy change allowing 100% non-Chinese ownership of hospitals and other health services, foreign and private ventures in China’s healthcare sector is projected to increase over time. In fact, the [...]
Part 3 of the report Asia healthcare Titans 2013 from Clearstate Pte Ltd. Source: More than 10% stake, deal worth more than US$ 15 million, target country Asia. Unless otherwise indicated, source: Bloomberg & EIU Zephyr databases Tej Deol, M.D.
Interesting article (click link) in The Singapore Straits Times today on a topic of increasing relevance to Singaporeans as they grapple with demographic challenges with respect to native population maintenance. With advanced economic development and increasing work-place participation of women, birth rates have been falling steadily and are now below natural population replacement rates causing [...]
Hospitals, especially level 3 hospitals, are seeing disproportionately high patient volumes due to overwhelming patient preference over primary health facilities; RMB 16.5 bil budgeted for 2009-2011 to expand primary healthcare infrastructure and address the imbalance, implying a shift in growth opportunities from urban to rural / lower tier cities.
Struggle to combat infectious diseases while manage rapid growth of chronic diseases in India: Significant economic burden with estimated 50 million diabetics and high mortality rate due to chronic diseases such as cardiovascular disease India has the second largest population in the world and its GDP is ranked 9th in the world. The healthcare sector [...]
Transition from infectious diseases to rise of chronic diseases, with more than 2.2 Million new cases of cancer annually, and 1 in 5 adults suffering from cardiovascular disease Home to a population of 1.3 billion people, China is now the world’s largest economy after the US. China’s healthcare and disease profiles are undergoing significant changes [...]
A highly heterogeneous region, Asia has established itself as one of the most exciting and challenging markets across many industries, but particularly so for healthcare products and services. Beyond price affordability issues, logistical challenges, and the regulatory labyrinths, many parts of Asia are also plagued by cultural barriers, especially for women’s health management. The lack [...]
First of all, a big thank you to the folks at asiahealthspace.com for the warm welcome. I am very much looking forward to contributing to the space. In the next 2 – 3 years the much talked about patent cliff in the pharmaceutical industry will gain real momentum and traction. Some estimates value the impending [...]
This insightful article was provided to us by one of our contributors James J. Gillespie, President, Center for Healthcare Innovation and Brian Speicher, MBA Candidate, Sloan School of Management, MIT. “To a great extent, we have lost control of the data and, in many ways, our traditional position as information providers. Patients and others now [...]
Last week I attended a Health Informatics conference in KL. Although I met some interesting people which happened to be my primary purpose anyway, not much else of significance was learned from the conference. Well-intentioned bureaucrats describing the desperate needs to connect Health care across the delivery spectrum and how they have struggled to build [...]